Back
Stellantis NV Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
22
STLA
Stellantis NV
Last Price:
$11.82
Seasonality Move:
-4.01%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$271.02
Seasonality Move:
7.6%
Sell
22
Stellantis NV (STLA)
is a Sell
Is Stellantis NV a Buy, Sell or Hold?
-
The current Stellantis NV [STLA] share price is $11.81. The Score for STLA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
STLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $271.02. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STLA Stock Price Chart
What is Stellantis NV's stock price today?
-
The Stellantis NV share price today is $11.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $271.02The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
STLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 39.24 | Sell |
Chaikin Money Flow: | 21754043 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.99 - 13.35) | Sell |
Bollinger Bands (100): | (12.5 - 13.6) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.53 | Buy |
Relative Strength Index (14 RSI): | 57.28 | Buy |
Chaikin Money Flow: | 106003 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.42 - 267) | Buy |
Bollinger Bands (100): | (240.58 - 270.64) | Buy |
STLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.25 | Sell |
20-day SMA: | 12.37 | Sell |
50-day SMA: | 12.91 | Sell |
200-day SMA: | 15.01 | Sell |
8-day EMA: | 12.17 | Sell |
20-day EMA: | 12.45 | Sell |
50-day EMA: | 12.8 | Sell |
200-day EMA: | 15.04 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 268.31 | Buy |
20-day SMA: | 253.84 | Buy |
50-day SMA: | 259.68 | Buy |
200-day SMA: | 253.36 | Buy |
8-day EMA: | 268.69 | Buy |
20-day EMA: | 260.57 | Buy |
50-day EMA: | 257.45 | Buy |
200-day EMA: | 244.33 | Buy |
Stellantis NV Earnings Growth & STLA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.67 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Stellantis NV Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |